local anesthetic drug
Scope
Date
~
-
Bio & Pharma
Dong-A ST incorporates NeuroBo as subsidiary
Dong-A ST said on Friday that it would acquire American drug company NeuroBo Pharmaceuticals as a subsidiary.NeuroBo, located in Boston, is a Nasdaq...
Dec 23, 2022 (Gmt+09:00)
-
Rights offerings
SK Innovation to inject $1.6 bn into SK On's rights offering
South Korea's top refiner SK Innovation Co. said on Dec. 21 it will invest 2 trillion won ($1.6 billion) in its electric battery maker unit SK On Co...
Dec 22, 2022 (Gmt+09:00)
-
Tech, Media & Telecom
KETI localizes core software for metal 3D printing
Korea Electronics Technology Institute (KETI) on Tuesday said it developed domestic software to boost quality in manufacturing using metal 3D printe...
Dec 21, 2022 (Gmt+09:00)
-
Bio & Pharma
S.Korean biopharmaceutical sector to see brisk M&As in H1, 2023
An expert says the first half of next year will see the start of brisk M&As in biopharmaceuticals targeting strategic investors.Pyeon Jae-seong,...
Dec 21, 2022 (Gmt+09:00)
-
Artificial intelligence
Syntekabio launches new drug development platform STB Cloud in US
Syntekabio,Inc., a South Korean artificial intelligence (AI) drug development company, said on Monday it has launched its cloud-based AI drug develo...
Dec 19, 2022 (Gmt+09:00)
-
Bio & Pharma
LG Chem in $95.5 million drug out-licensing deal with China’s Innovent
LG Chem Life Sciences, the biopharmaceutical unit of LG Chem Ltd., and China’s biotech company Innovent Biologics have entered into a strategi...
Dec 15, 2022 (Gmt+09:00)
-
Bio & Pharma
Daewoong submits new drug applications for Fexuclue in 10 countries
South Korea's leading drug company Daewoong Pharmaceutical is accelerating its global expansion efforts for its 34th domestically developed drug Fex...
Dec 14, 2022 (Gmt+09:00)
-
Bio & Pharma
S. Korea's SillaJen launches clinical trials in US for new anti-cancer drug
South Korean biotech company Sillajen Inc. has started recruiting patients for Phase 1 clinical trials in the US for an anti-cancer drug from a Swis...
Dec 14, 2022 (Gmt+09:00)
-
Bio & Pharma
LG Chem confirms diabetes drug Zemidapa's efficacy in phase 3 trials
LG Chem Ltd. announced in a disclosure on Monday that it had confirmed superior efficacy in phase 3 clinical trials for the combined administration ...
Dec 13, 2022 (Gmt+09:00)
-
Bio & Pharma
S.Korean biotech firm Noul signs MOU with disease center of Ghana
South Korea's Medical diagnostics company Noul Co., Ltd. said on Monday that it has signed a memorandum of understanding with the Ghana Infectious D...
Dec 12, 2022 (Gmt+09:00)
-
Energy
Doosan Enerbility gets int'l certification for offshore wind power system
South Korea's heavy industry company Doosan Enerbility Co. on Monday said it is Korea's first to receive international certification for an eight-me...
Dec 12, 2022 (Gmt+09:00)
-
Bio & Pharma
New drug developer Onconic Therapeutics raises $20 mn in Series B
South Korean drug developer Onconic Therapeutics, announced on Friday that it raised 26 billion won ($19.9 million) in Series B funding, with cumula...
Dec 09, 2022 (Gmt+09:00)
-
Bio & Pharma
SK Biopharmaceuticals launches epilepsy drug in France
South Korean SK Biopharmaceuticals Co. said on Friday that its treatment of epilepsy "Cenobamate" has been approved for sale in France.The company l...
Dec 09, 2022 (Gmt+09:00)
-
Korean startups
Korean hospitality startup Jienem enters Vietnam with local partners
Guesthouse accommodation service provider Jienem is revving up to enter the Vietnamese market.The South Korean startup announced Wednesday that it s...
Dec 07, 2022 (Gmt+09:00)
-
Bio & Pharma
Korea approves Daewoong Pharmaceutical's diabetes drug
DAEWOONG PHARMACEUTICAL has received domestic approval for its diabetes drug Envlo with the active ingredient enavogliflozin, the second straight ye...
Dec 02, 2022 (Gmt+09:00)
-
Bio & Pharma
Spectrum to push back launch date of Hanmi-developed drug Poziotinib
Hanmi Pharmaceutical Co. announced Friday that California-based Spectrum Pharmaceuticals Inc. received a Complete Response Letter (CRL) from the US ...
Nov 25, 2022 (Gmt+09:00)
-
Central bank
BOK takes 25-bp rate hike as won rebounds against dollar
South Korea’s central bank raised the base interest rate by 25 basis points to 3.25% during its monetary policy board meeting on Nov. 24, slow...
Nov 24, 2022 (Gmt+09:00)
-
Bio & Pharma
Mezzion Pharma to try again for US FDA approval of drug
South Korea's Mezzion Pharma will seek to get the oral medicine Udenafil to treat side effects from heart surgery, planning to clinical trials in th...
Nov 23, 2022 (Gmt+09:00)
-
Korean food
CJ CheilJedang serves up K-food for Qatar World Cup fans
South Korean food giant CJ CheilJedang Corp. said on Tuesday it is operating a Korean food section within the Qatar World Cup’s fan zone, mana...
Nov 22, 2022 (Gmt+09:00)
-
Corporate bonds
KEPCO turns from bonds to banks for money on govt plans
Korea Electric Power Corp. (KEPCO) is set to raise 600 billion won ($442 million) from a local bank in a plan to seek loans to secure money instead ...
Nov 21, 2022 (Gmt+09:00)
-
Banking & Finance
Daol Investment seeks to sell Thai subsidiary, eyes $75 mn in proceeds
South Korea’s Daol Investment & Securities Co. plans to sell a controlling stake in its Thai subsidiary, Daol Thailand PCL, as part of its...
Nov 18, 2022 (Gmt+09:00)
-
Batteries
SK Nexilis bolsters ties with Polish, Korean cities for sustainable growth
South Korean copper foil producer SK Nexilis Co. on Nov. 7 signed an MOU with the authorities of two cities — Jeongeup, Korea, and Stalowa Wol...
Nov 07, 2022 (Gmt+09:00)
-
Mergers & Acquisitions
Foreign PE firms on hunt for Korea Inc. with strong dollar
Foreign private equity firms have taken advantage of the strong dollar to dominate corporate acquisition deals in South Korea, adding to expectation...
Nov 01, 2022 (Gmt+09:00)
-
Bio & Pharma
No more ineffective drugs due to resistance
L-Base is a pharmaceutical startup specializing in developing drugs for those who become resistant to existing cancer treatments. This year, the Minis...
Nov 01, 2022 (Gmt+09:00)
-
Korean chipmakers
Samsung to use rare gas produced by POSCO for chip manufacturing
Samsung Electronics Co., the world’s largest memory chipmaker, will significantly raise the use of locally produced xenon, a critical gas for ...
Oct 28, 2022 (Gmt+09:00)
-
Corporate bonds
Korea's $35 bn plan yet to ease Legoland default woes
South Korea’s $35 billion rescue plan provided a temporary painkiller to the domestic bond markets rattled by Legoland Korea developer’s...
Oct 25, 2022 (Gmt+09:00)
-
Bio & Pharma
Moderna to stay ahead in mRNA technology: CSO Melissa Moore
CAMBRIDGE, MA – The COVID-19 coronavirus disease has been a curse for many people and companies around the world over the past couple of years...
Oct 14, 2022 (Gmt+09:00)
-
Bio & Pharma
SillaJen shares jump as exchange maintains listing, allows resumed trade
Shares in South Korea’s scandal-hit biotechnological company SillaJen Inc. soared on Thursday after the local exchange decided to maintain the...
Oct 13, 2022 (Gmt+09:00)
-
Machinery
Japan, Spain firms join forces with Woojin for Korean bullet train bid
A Japanese company and a Spanish firm have joined hands with a South Korean company for a local bullet train supply deal as the country is expected ...
Oct 10, 2022 (Gmt+09:00)
-
Korean chipmakers
SK Hynix hikes use of locally produced neon gas for chip manufacture
SK Hynix Inc., the world’s second-largest memory chipmaker, said on Wednesday it will significantly raise the use of locally produced neon, a ...
Oct 05, 2022 (Gmt+09:00)